Management Consulting completes US acquisition
Business consultancy Management Consulting Group has completed the acquisition of New Albany Healthcare Consultants, announced in May.
Business consultancy Management Consulting Group has completed the acquisition of New Albany Healthcare Consultants, announced in May.
New Albany provides consulting services related to performance improvement in clinical operations in hospitals and medical practices across the US.
Management Consulting subsidiary Kurt Salmon made the purchase for a total consideration of $0.8m. A team of five senior consultants from the business has joined the healthcare practice of Kurt Salmon, which Management Consulting believes brings "an important additional capability to Kurt Salmon's healthcare consulting offering" in the US.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Nick Stagg, Chief Executive said: "New Albany brings years of experience in clinical operations, that, combined with Kurt Salmon's deep industry expertise, will provide opportunities to further develop our healthcare consulting practice in the United States. We will continue to look for opportunities to grow our business through small acquisitions."
NR
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge